MIV Therapeutics Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From MIV Therapeutics Inc.
The Future of Drug-Eluting Stents Part I: Novel Next-Generation Designs
Growth by innovation is almost considered a birthright in interventional cardiology, and based on presentations at this year's Transcatheter Cardiovascular Therapeutics meeting, held this September in San Francisco, it seems clear that innovation still reigns supreme in this specialty. However, as in other medical device markets, ongoing economic and regulatory pressures are taking their toll, particularly in the drug-eluting stent market, as the field adjusts to a new era of cost control and economic uncertainty.
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q3 2007
In this issue, we present another installment of our quarterly review of medical device and in vitro diagnostics/research dealmaking-for July-September 2007. Our data are derived from Windhover's Strategic Transactions Database.
Deals Update (09/2007)
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Dealmaking Roundup March 2007
Summary of recent device mergers and acquisitions, alliances, and financings.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Other Names / Subsidiaries
-
- MIVI Technologies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice